Loading clinical trials...
Loading clinical trials...
First Prospective Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease After Coronary Physiological Testing
Conditions
Interventions
Bisoprolol
Diltiazem
+1 more
Locations
15
Germany
Kerckhoff-Klinik gGmbH
Bad Nauheim, Germany
Herz- und Diabeteszentrum NRW
Bad Oeynhausen, Germany
Charité University Medicine Berlin, Campus Benjamin Franklin
Berlin, Germany
Universitätsklinikum Erlangen
Erlangen, Germany
Universitätsklinikum Frankfurt
Frankfurt, Germany
Universitäres Herz- und Gefäßzentrum UKE Hamburg
Hamburg, Germany
Start Date
March 4, 2022
Primary Completion Date
June 1, 2024
Completion Date
June 1, 2024
Last Updated
March 24, 2022
NCT07093528
NCT06991322
NCT07196397
NCT05984537
NCT06795035
NCT06597851
Lead Sponsor
Charite University, Berlin, Germany
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions